Literature DB >> 24711074

MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling.

Yingbin Hu1, Jingshi Liu, Bonian Jiang, Juying Chen, Zhongpin Fu, Fei Bai, Jiarui Jiang, Ziyuan Tang.   

Abstract

BACKGROUND: Discoidin domain receptors1 (DDR1) is associated with tumor progression, and its dysregulated expression has been observed in many cancers. AIM: We aim to explore molecular mechanism underlying the role of DDR1 in colorectal cancer development.
METHODS: Immunohistochemistry and Western blot were applied to examine the DDR1 expression. Real-time RT-PCR and Western blot were performed to determine the expression of miR-199a-5p and DDR1. Luciferase reporter assay was used to determine whether DDR1 was a target of miR-199a-5p. Effects of miR-199a-5p and DDR1 on colorectal cell proliferation, colony formation, cell cycle progression, invasion and migration were then investigated. Western blot was used to determine the relative signal pathways.
RESULTS: Increased DDR1 and decreased miR-199a-5p expression coexisted in CRC, knockdown of DDR1 or overexpression of miR-199a-5p both resulted in reduced colony formation, invasive and migratory capabilities of human CRC LOVE1 and LOVO cells. It was also found that overexpression of miR-199a-5p led to decreased DDR1, MMP2, N-cadherin and vimentin expression and increased E-cadherin expression in both CRC cell lines. However, down-regulation of miR-199a-5p resulted in the opposite effects. Dual luciferase reporter assay confirmed that miR-199a-5p could directly target DDR1 through binding to its 3'-UTR.
CONCLUSIONS: Our findings indicated that up-regulation of DDR1 induced by miR-199a-5p down-regulation may contribute to the development and progression of CRC, and this effect may be associated with increased invasiveness, at least in part, via activating the EMT-related signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24711074     DOI: 10.1007/s10620-014-3136-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 2.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

4.  E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.

Authors:  Remco van Horssen; Antoinette Hollestelle; Joost A P Rens; Alexander M M Eggermont; Mieke Schutte; Timo L M Ten Hagen
Journal:  Breast Cancer Res Treat       Date:  2012-09-29       Impact factor: 4.872

Review 5.  Alterations of microRNAs contribute to colon carcinogenesis.

Authors:  Aaron J Schetter; Curtis C Harris
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

6.  Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines.

Authors:  Jing-Yuan Fang; Juan Lu; Ying-Xuan Chen; Li Yang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.

Authors:  Qingli Shen; Vito R Cicinnati; Xiaoyong Zhang; Speranta Iacob; Frank Weber; Georgios C Sotiropoulos; Arnold Radtke; Mengji Lu; Andreas Paul; Guido Gerken; Susanne Beckebaum
Journal:  Mol Cancer       Date:  2010-08-27       Impact factor: 27.401

8.  Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.

Authors:  Keiji Shimada; Mitsutoshi Nakamura; Eiwa Ishida; Tomonori Higuchi; Hiroshi Yamamoto; Kazutake Tsujikawa; Noboru Konishi
Journal:  Cancer Sci       Date:  2007-10-29       Impact factor: 6.716

9.  Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.

Authors:  C E Ford; S K Lau; C Q Zhu; T Andersson; M S Tsao; W F Vogel
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

10.  miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer.

Authors:  S-F Su; Y-W Chang; C Andreu-Vieyra; J Y Fang; Z Yang; B Han; A S Lee; G Liang
Journal:  Oncogene       Date:  2012-10-22       Impact factor: 9.867

View more
  39 in total

1.  MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway.

Authors:  Ali Hashemi Gheinani; Fiona C Burkhard; Hubert Rehrauer; Catharine Aquino Fournier; Katia Monastyrskaya
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

2.  Reducing interferon'ce in stem cells.

Authors:  Alycia Gardner; Brian Ruffell
Journal:  Nat Cell Biol       Date:  2017-05-31       Impact factor: 28.824

3.  miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-κB1 in human ovarian cancer cells.

Authors:  Xiaoxiao Liu; Baofeng Yao; Zhiming Wu
Journal:  Oncol Lett       Date:  2018-07-18       Impact factor: 2.967

4.  The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis.

Authors:  Mingwen Che; Tiantian Shi; Shidong Feng; Huan Li; Xiaomin Zhang; Ning Feng; Weijuan Lou; Jianhua Dou; Guangbo Tang; Chen Huang; Guoshuang Xu; Qi Qian; Shiren Sun; Lijie He; Hanmin Wang
Journal:  J Am Soc Nephrol       Date:  2017-04-20       Impact factor: 10.121

5.  MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells.

Authors:  Yusheng Li; Wei Jiang; Yuling Hu; Zixun Da; Chao Zeng; Min Tu; Zhenhan Deng; Wenfeng Xiao
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

Review 6.  An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.

Authors:  Wenhao Weng; Junlan Feng; Huanlong Qin; Yanlei Ma; Ajay Goel
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

7.  A microRNA binding site polymorphism in the 3' UTR region of VEGF-A gene modifies colorectal cancer risk based on ethnicity: a meta-analysis.

Authors:  Sai Sushmitha Kontham; Charles Emmanuel Jebaraj Walter; Zioni Sangeetha Shankaran; Arvind Ramanathan; Nirmala Karuppasamy; Thanka Johnson
Journal:  J Egypt Natl Canc Inst       Date:  2022-04-25

Review 8.  Prognostic and Clinicopathologic Significance of Discoidin Domain Receptors in Different Human Malignancies: A Meta-Analysis.

Authors:  Gordon A Ferns; Sheida Shabanian; Milad Shahini Shams Abadi; Ahmadshah Farhat; Mohammad-Hassan Arjmand
Journal:  Gastrointest Tumors       Date:  2021-08-05

Review 9.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

10.  Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma.

Authors:  Ling-Fei Zhang; Jia-Tao Lou; Ming-Hua Lu; Chunfang Gao; Shuang Zhao; Biao Li; Sheng Liang; Yong Li; Dangsheng Li; Mo-Fang Liu
Journal:  EMBO J       Date:  2015-09-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.